Neurontin

Parke-Davis Div of Pfizer Inc🇺🇸 United States

FDA Page

Effective Date: Jul 12, 2022
Approval ID: ee9ad9ed-6d9f-4ee1-9d7f-cfad438df388
Products: 6 registered
Version: 47

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use NEURONTIN safely and effectively. See full prescribing information for NEURONTIN. NEURONTIN (gabapentin) capsules, for oral use NEURONTIN (gabapentin) tablets, for oral use NEURONTIN (gabapentin) oral solution Initial U.S. Approval: 1993

Quick Stats

Total Products6

Labelers2

Label Sections52

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.